{
    "nct_id": "NCT02925650",
    "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects of Posiphen\u00ae in Subjects With Early Alzheimer's Disease (AD)",
    "status": "COMPLETED",
    "last_update_time": "2023-05-06",
    "description_brief": "This study evaluates the safety and pharmacological effects of 3 different doses of Posiphen\u00ae when compared to a placebo, in adult male and female patients with early Alzheimer's disease (AD).",
    "description_detailed": "Posiphen\u00ae, which was discovered by the US National Institute on Aging (NIA) is a small, orally active, experimental drug that specifically inhibits the synthesis of amyloid precursor protein (APP), Tau and \u03b1-Synuclein. It is distinct from other Alzheimer's disease drugs currently in development, because it inhibits the formation of several toxic proteins, rather than removing individual toxic protein after they are produced. Posiphen has potential utility as a disease modifying treatment for AD. The present study will confirm the pharmacokinetics (PK) of Posiphen and its metabolites in plasma and cerebral spinal fluid (CSF). It will also measure the effects of a 23-25 day treatment period with Posiphen on the CSF and plasma levels of a number of biomarkers, inflammatory factors and control proteins. It will also expand the safety data in humans by extending the treatment period from 10 days to a treatment period from 23-25 days. In addition, this study will measure concentrations of various soluble biomarkers in CSF and use the SILK\u2122 assay methods to directly measure the effect of Posiphen on the fractional synthesis rate of A\u03b240 in CSF, which will help guide the further development of Posiphen and determine the feasibility of SILK\u2122 in a multicenter trial.",
    "phase": [
        "PHASE1",
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Low Dose",
                    "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "FG001",
                    "title": "Medium Dose",
                    "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "FG002",
                    "title": "High Dose",
                    "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "FG003",
                    "title": "Placebo",
                    "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "7"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Low Dose",
                    "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "BG001",
                    "title": "Medium Dose",
                    "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "BG002",
                    "title": "High Dose",
                    "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                },
                {
                    "id": "BG003",
                    "title": "Placebo",
                    "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                },
                {
                    "id": "BG004",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "5"
                        },
                        {
                            "groupId": "BG001",
                            "value": "5"
                        },
                        {
                            "groupId": "BG002",
                            "value": "1"
                        },
                        {
                            "groupId": "BG003",
                            "value": "7"
                        },
                        {
                            "groupId": "BG004",
                            "value": "18"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "5"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "13"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "8"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race/Ethnicity, Customized",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "White",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "17"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Unknown, Not Reported",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Not-Hispanic or Latino",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "17"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hispanic or Latino",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "18"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Safety and Tolerability of Multiple Ascending Doses of Posiphen: Reports of Adverse Events or Study Discontinuations",
                    "description": "Number of adverse events or study discontinuations, broken down by dose arm (i.e. Low vs. Medium vs. High vs. Placebo), and further broken down by relatedness to Posiphen (Definitely Related, Probably Related, Possibly Related, Unlikely Related, Unrelated)",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "events",
                    "timeFrame": "Up to 25 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Definitely Related",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Probably Related",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Possibly Related",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Unlikely Related",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Unrelated",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "The Levels of Posiphen and Its Metabolites Will be Determined in Plasma",
                    "description": "Mean plasma concentrations of levels of posiphen tartrate, N1 desmethyl posiphen, and N8 desmethyl Posiphen metabolite were determined for each of the three dose cohorts (Low Dose, Medium Dose, High Dose) by a protein precipitation extraction method using a high performance liquid chromatographic mass spectrometric detection method, with a linear weighted regression to determine their concentrations.",
                    "populationDescription": "Participants in the Placebo Arm/Group were not given study drug. Therefore, measurements of study drug, Posiphen, and its metabolites were not performed on the Placebo Arm/Group.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "The confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window. Plasma was collected at 0, 2, 4, 8, 12, 16, 20, and 24hrs during the confinement visit.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Posiphen",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "7.16",
                                            "spread": "4.25"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "9.51",
                                            "spread": "5.77"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "12.01",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "N1 metabolite",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.29",
                                            "spread": "0.77"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.02",
                                            "spread": "1.4"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2.51",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "N8 metabolite",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.25",
                                            "spread": "1.36"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5.04",
                                            "spread": "1.8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "3.35",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "The Levels of Posiphen and Its Metabolites Will be Determined in Cerebrospinal Fluid (CSF)",
                    "description": "Mean CSF concentrations of levels of posiphen tartrate, N1 desmethyl posiphen, and N8 desmethyl Posiphen metabolite were determined for each of the three dose cohorts (Low Dose, Medium Dose, High Dose) by a protein precipitation extraction method using a high performance liquid chromatographic mass spectrometric detection method, with a linear weighted regression to determine the concentrations.",
                    "populationDescription": "Participants in the Placebo Arm/Group were not given study drug. Therefore, measurements of study drug, Posiphen, and its metabolites were not performed on the Placebo Arm/Group.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "The confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window. Plasma was collected at 0, 2, 4, 8, 12, 16, 20, and 24hrs during the confinement visit.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Posiphen",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.46",
                                            "spread": "0.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.73",
                                            "spread": "0.52"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.71",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "N1 metabolite",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.02",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.28",
                                            "spread": "0.3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "N8 metabolite",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.35",
                                            "spread": "0.26"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.77",
                                            "spread": "0.43"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.15",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Fractional Synthesis Rate of A\u03b240 in CSF Using the SILK\u2122 Technique With Multiple Doses of Posiphen",
                    "description": "The fractional synthesis rate (FSR) of A\u03b240 was measured in the CSF using the SILK\u2122 technique. FSR is a measure of the rate of A\u03b2 synthesis in the brain. During 13C6-leucine infusion, 13C6-leucine is incorporated into newly synthesized proteins throughout the body, including the brain, in proportion to the available 13C6-leucine. This FSR is calculated as the rate of change of the ratio of 13C6-leucine-labeled A\u03b2 proteins to unlabeled A\u03b2 proteins in the lumbar CSF between 6 to 16 hours, normalized to the ratio of labeled to unlabeled leucine amino acid in plasma. It is reported as a fraction of 13C6-leucine-labeled to unlabeled A\u03b2 proteins per hour. The ratio of A\u03b2 in CSF containing 13C6-leucine to that containing unlabeled leucine is measured using mass spectrometry.",
                    "populationDescription": "15 participants completed the Confinement visit and had sufficient samples to enable this analysis",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "fraction labeled:unlabeled A\u03b240 per hr",
                    "timeFrame": "The confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window. CSF was collected between 6 and 16hrs during the confinement visit.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "5"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.0405",
                                            "lowerLimit": "0.0298",
                                            "upperLimit": "0.0431"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.0400",
                                            "lowerLimit": "0.0373",
                                            "upperLimit": "0.0511"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.0206",
                                            "lowerLimit": "0.0206",
                                            "upperLimit": "0.0206"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.0375",
                                            "lowerLimit": "0.0319",
                                            "upperLimit": "0.0449"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Feasibility of CSF Catheter Study With SILK\u2122 Technology to Evaluate Rates of Enrollment",
                    "description": "Feasibility of CSF Catheter Study with SILK\u2122 Technology was determined by comparing the total number of participants enrolled, randomized and treated with study drug in the trial to the total number of participants who completed the CSF Catheter Study across all participating sites.",
                    "populationDescription": "Overall number of participants completing the protocol",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 25 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active Treatment Arms",
                            "description": "Participants who were randomized to receive Active Treatment (Posiphen 60mg, 120mg or 180mg)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Arm",
                            "description": "Participants who were randomized to receive Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "11"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Feasibility of CSF Catheter Study With SILK\u2122 Technology to Evaluate %CSF Samples With Enough Volume for Testing",
                    "description": "The % of cerebrospinal fluid samples with sufficient volume for testing will be determined across study participants during the SILK sampling procedure",
                    "populationDescription": "The % of CSF samples with sufficient volume for testing will be determined across study participants during the SILK sampling procedure",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "percentage of CSF samples",
                    "timeFrame": "Up to 25 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "All Randomized Participants Who Completed 36 Hour Confinement Visit (n=15)",
                            "description": "Time points where sufficient CSF samples (6 ml) were collected across 285 time points (15 participants \\* 19 CSF collection time points)."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "81.75"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Feasibility of CSF Catheter Study With SILK\u2122 Technology to Evaluate Research Satisfaction",
                    "description": "Research satisfaction will be evaluated by qualitative response to 14 questions asked to participants about their experience with the study procedures. Responses will be grouped and reported by common themes",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "percentage of participants",
                    "timeFrame": "Up to 25 days",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "All Randomized Participants",
                            "description": "Responses to 14 questions from Research Satisfaction Survey (RSS) from all randomized participants"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "15"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Rated \"Excellent\" for quality of tests and attention received during participation in the study.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "94"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Almost all of my expectations have been met\" by the research program.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "81"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Yes, definitely\" they would recommend this research program to a friend.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "94"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Yes, definitely\" they would choose to participate again.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "87.5"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Volunteering\" as what they liked best about the study.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Time Commitment\" as what they liked least about the study.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Yes\", the 36 hour catheter procedure was done.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "100"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"No\" adverse events were associated with the 36hr catheter procedure.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "73"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Excellent\" as the quality of the 36hr catheter procedure and attention they received.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "80"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported the catheter procedure was \"almost all of what I expected.\"",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "67"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported they liked best was \"participating in cutting edge research and interacting with the team\".",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "100"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Other\" as what they liked least about the 36hr catheter procedure.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "47"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported \"Other\" as what they would change about the 36hr catheter procedure.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "71"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reported they would change the number of visits.",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "50"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Pharmacodynamic and PK-PD Effects on CSF Alzheimer's Disease Biomarkers",
                    "description": "A\u03b238, A\u03b240, A\u03b242, sAPP\u03b1, sAPP\u03b2, and T-Tau were sampled at Screening and at the start of the confinement visit. Results of these measures were reported as a least square means, calculated as the change between the measured values at the start of the confinement visit and Screening in ng/mL.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "CSF was sampled at Screening and at the start of the confinement visit, which occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active Treatment Arms",
                            "description": "Participants who were randomized to receive Active Treatment (Posiphen 60mg, 120mg or 180mg)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Arm",
                            "description": "Participants who were randomized to receive Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "A\u03b238",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.391",
                                            "spread": "0.173"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.593",
                                            "spread": "0.199"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "A\u03b240",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.73",
                                            "spread": "0.998"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.13",
                                            "spread": "1.151"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "A\u03b242",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.107",
                                            "spread": "0.0653"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.211",
                                            "spread": "0.0753"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sAPP\u03b1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.49",
                                            "spread": "5.75"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-3.5",
                                            "spread": "9.07"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sAPP\u03b2",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "19.1",
                                            "spread": "16.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-28.6",
                                            "spread": "26.5"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total Tau",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "186.4",
                                            "spread": "79.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "53.7",
                                            "spread": "124.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Assessment of Mental Status Effects",
                    "description": "The short-term effects of Posiphen on mental status will be measured using the Mini-Mental State Examination (MMSE). The MMSE is a brief, global cognitive measure that includes orientation, memory, attention, concentration, naming, writing, repetition, comprehension, and construction. The total score ranges from 0 (worst) to 30 (best performance). Results of the MMSE for this trial were reported as a raw change score, calculated as the change between the total scores at two evaluation time points (Baseline, Pre-Confinement Visit) and where negative values are worse and positive values are better.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "MMSE was administered at Baseline and at the Pre-Confinement Visit 1-3 days prior to the Confinement Visit. This confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.4",
                                            "spread": "0.89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.2",
                                            "spread": "2.39"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-1",
                                            "spread": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1.14",
                                            "spread": "2.12"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Assessment of Neuropsychiatric Effects",
                    "description": "The Neuropsychiatric Inventory (NPI) was used to measure the frequency and severity of neuropsychiatric symptoms. On this scale frequency ratings range from 0 (no symptoms) to 4 (very frequently, once or more per day or continuously). Severity ratings range from 0 (no severity) to 3 (severe). The score for each of 12 symptoms measured in the scale is the product of severity and frequency within that symptom. The total score for the NPI is the sum of all 12 symptom item scores, for a highest possible total score of 144 in individuals with maximal symptoms, and a lowest possible total score of zero (0) in fully asymptomatic individuals. Lower scores are better and higher scores indicate more neuropsychiatric symptoms. Results are calculated as the change between the total scores at two evaluation time points (Baseline, Pre-Confinement Visit) with negative scores being better and positive scores being worse.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "NPI was administered at Baseline and at the Pre-Confinement Visit 1-3 days prior to the Confinement Visit. This confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, while also allowing a +/- 2-day visit window.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Low Dose",
                            "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG001",
                            "title": "Medium Dose",
                            "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG002",
                            "title": "High Dose",
                            "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule"
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "5"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.6",
                                            "spread": "2.88"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.4",
                                            "spread": "8.47"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-9",
                                            "spread": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-3.86",
                                            "spread": "8.09"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Assessment of Cognitive Effects",
                    "description": "The short-term effects of Posiphen on cognition were measured using the The Alzheimer's Disease Assessment Scale-Cognitive 12 (ADAS-Cog12). The ADAS-Cog is a structured scale that evaluates memory (word recall, word recognition), reasoning, language (naming, comprehension), orientation, ideational praxis and constructional praxis. The test is scored in terms of errors, with higher scores reflecting poorer performance and greater impairment. Total ADAS-Cog12 scores can range from 0 to 80, with lower scores being better and higher scores being worse. Results of the ADAS-Cog12 for this trial are reported as a raw change score, calculated as the change between the total scores at two evaluation time points (Baseline, Pre-Confinement Visit) with negative scores being better and positive scores being worse.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "ADAS-Cog12 was administered at Baseline and at the Pre-Confinement Visit 1-3 days prior to the Confinement Visit. This confinement visit occurred following 21-23 days of treatment with either Posiphen or placebo, also allowing a +/- 2-day visit window.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active Treatment Arms",
                            "description": "Participants who were randomized to receive Active Treatment (Posiphen 60mg, 120mg or 180mg)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Arm",
                            "description": "Participants who were randomized to receive Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "11"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.55",
                                            "spread": "6.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.57",
                                            "spread": "5.19"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "From Randomization through Study Day 25.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Low Dose",
                    "description": "The study drug Posiphen dosage of 60mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 5,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 5,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 5
                },
                {
                    "id": "EG001",
                    "title": "Medium Dose",
                    "description": "The study drug Posiphen dosage of 120mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 5,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 5,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 5
                },
                {
                    "id": "EG002",
                    "title": "High Dose",
                    "description": "The study drug Posiphen dosage of 180mg is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPosiphen: oral solid dosage form capsule",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 1,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 1,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 1
                },
                {
                    "id": "EG003",
                    "title": "Placebo",
                    "description": "The Placebo comparator is to be taken orally in divided doses, three times per day for a total 23-25 days.\n\nPlacebo: oral solid dosage form capsule",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 7,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 7,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 7
                }
            ],
            "otherEvents": [
                {
                    "term": "agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "catheter site swelling",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "fatigue",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 3,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "injection site pain",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "injection site swelling",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "lethargy",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "medical device complication",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "musculoskeletal pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "musculoskeletal stiffness",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "nasal congestion",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "neck pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "pain in extremity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "pain in jaw",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "paraesthesia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "post lumbar puncture syndrome",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "productive cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "rhinitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "sunburn",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "traumatic lumbar puncture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "tremor",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 2,
                            "numAtRisk": 7
                        }
                    ]
                },
                {
                    "term": "urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 18.00",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 5
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 1
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 7
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Howard Feldman MDCM, FRCP(C)",
                "organization": "Alzheimer's Disease Cooperative Study",
                "email": "hhfeldman@health.ucsd.edu",
                "phone": "858-246-1347"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "Posiphen (oral small-molecule translational inhibitor of APP/A\u03b2 synthesis)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests Posiphen in early AD and describes an orally active small molecule that reduces production of APP and A\u03b2 by binding an iron-responsive element in APP mRNA and inhibiting APP translation \u2014 i.e., it targets Alzheimer\u2019s pathology (amyloid production) rather than acting as a symptomatic cognitive enhancer or psychiatric agent. \ue200cite\ue202turn0search2\ue202turn0search5\ue201",
        "Act: Extracted trial details \u2014 title and design: a multicenter, randomized, double-blind, placebo-controlled, ascending-dose PK/PD and safety study of Posiphen (compared to placebo) in early AD (NCT02925650). The publication and preprints report Posiphen is an orally administered small molecule that lowers APP production (and thereby A\u03b2), with supportive PK/PD and safety data from the Phase 1b study. \ue200cite\ue202turn0search4\ue202turn0search0\ue202turn0search3\ue201",
        "Reflect: Classification check \u2014 because Posiphen is a small-molecule drug with a mechanism that directly targets disease biology (translation of APP and reduction of A\u03b2), the correct category is 'disease-targeted small molecule'. The trial compares multiple doses to placebo and measures biomarker (A\u03b2/APP) kinetics; there is no indication it is a biologic (e.g., antibody), a pure symptomatic cognitive enhancer, or focused on neuropsychiatric symptom relief. Note: some trial registry text fields can be inconsistent, but the peer-reviewed and translational literature consistently describe Posiphen as a small-molecule translational inhibitor of APP. \ue200cite\ue202turn0search2\ue202turn0search5\ue201"
    ],
    "agent_type": "A) Amyloid beta",
    "explanation_agent": [
        "Reason: The investigational drug Posiphen is described as an oral small-molecule translational inhibitor that binds an iron\u2011responsive element (IRE) in the 5'\u2011UTR of APP mRNA to reduce APP translation and downstream A\u03b2 production \u2014 i.e., it directly targets amyloid production, the hallmark of CADRO category A. \ue200cite\ue202turn0search0\ue202turn0search4\ue201",
        "Act: Extracted details and assignment \u2014 the trial (NCT02925650) is a multicenter, randomized, double\u2011blind, placebo\u2011controlled, ascending\u2011dose PK/PD and safety study of Posiphen in early AD. The translational and clinical literature report dose\u2011dependent lowering of APP production and effects on A\u03b2/APP biomarkers with Posiphen, so the most specific CADRO match is 'A) Amyloid beta'. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Reflect: Confirmation \u2014 Posiphen\u2019s mechanism (inhibiting APP translation to reduce A\u03b2) is disease\u2011targeted and directly addresses amyloid biology rather than, for example, tau, inflammation, neurotransmitter modulation, or a non\u2011therapeutic procedure. There is no indication the trial is multi\u2011target or diagnostic only, so 'A) Amyloid beta' is the correct CADRO classification.",
        "Web search results supporting classification (brief): (1) Translational inhibition of APP by Posiphen \u2014 preclinical pharmacology and mechanism describing APP 5'\u2011UTR/IRE mechanism and reduction of APP/A\u03b2. \ue200cite\ue202turn0search0\ue202turn0search4\ue201 (2) Multicenter randomized ascending\u2011dose Posiphen study in early AD \u2014 full\u2011text report of safety, PK/PD and biomarker (SILK) analyses (NCT02925650). \ue200cite\ue202turn0search2\ue201 (3) PubMed entry summarizing the Posiphen early\u2011AD trial outcomes and biomarker findings. \ue200cite\ue202turn0search1\ue201"
    ]
}